Aprocitentan Reduces Resistant Hypertension in CKD Aprocitentan Reduces Resistant Hypertension in CKD

The findings provide support for potentially using aprocitentan in patients with BP that remains elevated despite treatment with three established antihypertensive drug classes and with stage 3 CKD.MDedge News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news